Axogen, Inc. - 8-K Filing

Axogen, Inc. announces strategic expansion into the prostate market with Avance® nerve reconstruction technology. (Items: 7.01 Regulation FD DisclosureOn November 9, 2026, Axogen, Inc, 9.01 Financial Statements and Exhibits(d) ExhibitsExhibit No)

SEC EDGAR · November 9, 2026, 13:52 UTC

Tickers: $AXGN

Read the full article at SEC EDGAR

Part of the story Axogen, Inc. - 8-K Filing (3 articles)

More Regulatory news

SusGlobal Energy Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 14:42 UTC
Ideal Power Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:25 UTC
DIGI INTERNATIONAL INC - 8-K Filing SEC EDGAR · November 12, 2026, 14:23 UTC
ZeroStack Corp. - 8-K Filing SEC EDGAR · November 12, 2026, 14:22 UTC
Sound Point Meridian Capital, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:22 UTC
Boost Run Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:20 UTC
INTERFACE INC - 8-K Filing SEC EDGAR · November 12, 2026, 14:20 UTC
Neonode Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 14:20 UTC
Virtuix Holdings Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:20 UTC
Neonode Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:18 UTC